Ro (Roman Health)
Ro is a direct-to-patient healthcare company that connects patients with licensed providers through telehealth. It supports care delivery with pharmacy services, lab testing, and medication delivery, plus options for at-home diagnostics and in-home care. Ro also offers products such as Workpath for coordinating in-home care and Kit for at-home testing.
Founded by Zachariah Reitano (Co-Founder & CEO), Saman Rahmanian (Co-Founder & Chief Product Officer), Rob Schutz (Co-Founder & Chief Growth Officer)
| Round | Announced | Raised | Post-money |
|---|---|---|---|
| Series D | Feb 15, 2022 | $150M | $7B |
| Series D | Mar 23, 2021 | $500M | $5B |
| Series C | Jul 27, 2020 | $200M | $1.5B |
| Series B | Apr 15, 2019 | $85M | $500M |
| Series A | Sep 17, 2018 | $88M | $436.3M |
- FIFirstMark
- GCGeneral Catalyst
- TVTQ Ventures
- BOBoxGroup
- ICInitialized Capital
- SISignalFire
- TCTCG
- 3C3L Capital
- ACAltimeter Capital
- SSSeven Seven Six
| Kind | Implied valuation | Price / share | Date |
|---|---|---|---|
| $3.5B | — | Aug 25, 2026 | |
| $2.4B | $5.50 | Jul 29, 2026 | |
| $2.3B | $5.00 | Jul 24, 2026 |
Invest in the private markets on Legion
Registered users see full trading activity, every investor, rankings, and live deals.
Data as of Oct 16, 2026. Valuations are estimates blended from primary and secondary-market signals — not investment advice.